Literature DB >> 17374958

Research on the age-related changes in the nitric oxide pathway in the arteries of rats and the intervention effect of dehydroepiandrosterone.

Saizhu Wu1, Yunjun Ruan, Mengzhuo Yin, Wenyan Lai.   

Abstract

BACKGROUND: Aging, especially the aging of blood vessels, is a dangerous independent factor in the occurrence and development of cardiovascular and cerebrovascular diseases. However, the cellular and molecular pathologic mechanisms underlying the aging of blood vessels remain unclear.
PURPOSE: To observe changes in the nitric oxide (NO) pathway and the interventional effects of dehydroepiandrosterone (DHEA) in the artery during the aging process.
METHODS: Male Wistar rats were divided into 3 experimental groups of 6 rats each: group 1, adult control 12-month-old rats fed conventional fodder; group 2, 18-month-old rats fed conventional fodder, and group 3, 18-month-old rats that received 1 mg/kg/ DHEA in their fundamental fodder when they were 12 months old. The thoracic aorta was chosen. Endothelial NO synthase protein was measured using the Western blot method, the amount of NO using the Griess method, the amount of cGMP using radioimmunoassay, and the activity of superoxide dismutase (SOD) and the amount of malonyldialdehyde (MDA) using colorimetry. RESULT: Compared with the adult group, in the aortas of 18-month-old rats the protein expression of endothelial NO synthase (eNOS) is lower; the activity of SOD is lower but the amount of MDA is higher; the amounts of NO and cGMP are lower, but after DHEA intervention these changes are apparently ameliorated in the aged group.
CONCLUSION: During the aging process in rat arteries, the expression of eNOS is lowered, the function of oxidation resistance is weakened, and the response of the vascular smooth muscle to NO is apparently decreased. DHEA is able to ameliorate the function of NO-related signal pathways and delay the aging process of the blood vessels. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17374958     DOI: 10.1159/000100961

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  7 in total

1.  Dehydroepiandrosterone protects against oxidative stress-induced endothelial dysfunction in ovariectomized rats.

Authors:  João Paulo Gabriel Camporez; Eliana Hiromi Akamine; Ana Paula Davel; Celso Rodrigues Franci; Luciana Venturini Rossoni; Carla Roberta de Oliveira Carvalho
Journal:  J Physiol       Date:  2011-03-14       Impact factor: 5.182

2.  Upregulation of cyclooxygenase-2 expression in porcine macula densa with chronic nitric oxide synthase inhibition.

Authors:  M Kommareddy; R M McAllister; V K Ganjam; J R Turk; M Harold Laughlin
Journal:  Vet Pathol       Date:  2010-12-15       Impact factor: 2.221

3.  Thymoquinone improves aging-related endothelial dysfunction in the rat mesenteric artery.

Authors:  Noureddine Idris-Khodja; Valérie Schini-Kerth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-04-12       Impact factor: 3.000

4.  Grape-derived polyphenols improve aging-related endothelial dysfunction in rat mesenteric artery: role of oxidative stress and the angiotensin system.

Authors:  Noureddine Idris Khodja; Thierry Chataigneau; Cyril Auger; Valérie B Schini-Kerth
Journal:  PLoS One       Date:  2012-02-27       Impact factor: 3.240

5.  Differential modulation of nitric oxide synthases in aging: therapeutic opportunities.

Authors:  Stefany B A Cau; Fernando S Carneiro; Rita C Tostes
Journal:  Front Physiol       Date:  2012-06-25       Impact factor: 4.566

Review 6.  The role of oxidative stress and inflammation in cardiovascular aging.

Authors:  Junzhen Wu; Shijin Xia; Bill Kalionis; Wenbin Wan; Tao Sun
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

7.  Resveratrol attenuates hydrogen peroxide-induced aging through upregulation of autophagy in human umbilical vein endothelial cells.

Authors:  Ligen Du; Enping Chen; Ting Wu; Yunjun Ruan; Saizhu Wu
Journal:  Drug Des Devel Ther       Date:  2019-02-22       Impact factor: 4.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.